Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2013-08-22
Original market date: See footnote 1
2007-02-26
Product name:
AMPHOTEC 50 MG
DIN:
02241750
Product Monograph/Veterinary Labelling:
Date:
2006-01-12
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
THREE RIVERS PHARMACEUTICALS LLC
119 Commonwealth Drive
Warrendale
Pennsylvania
United States
15086
Class:
Human
Dosage form(s):
Powder For Suspension
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:14.28
Anatomical Therapeutic Chemical (ATC): See footnote 4
J02AA01 AMPHOTERICIN B
Active ingredient group (AIG) number:See footnote5
0105864001
| Active ingredient(s) | Strength |
|---|---|
| AMPHOTERICIN B | 50 MG / VIAL |